High-Risk Localized and Locally Advanced Prostate Cancer

Around 20%–30% of nonmetastatic prostate cancer patients have high-risk localized disease. The best treatment for high-risk localized disease is still unclear, and the reliability of the definition of “high-risk” may need to be validated first. Although recent advances in radiotherapy for prostate c...

Celý popis

Uloženo v:
Podrobná bibliografie
Korporativní autor: Izumi, Kouji
Médium: Livro
Jazyk:Inglês
Vydáno: MDPI - Multidisciplinary Digital Publishing Institute 2023
Témata:
thema EDItEUR::T Technology, Engineering, Agriculture, Industrial processes::TB Technology: general issues
thema EDItEUR::T Technology, Engineering, Agriculture, Industrial processes::TC Biochemical engineering::TCB Biotechnology
imaging modality
&nbsp
oligometastasis
radical prostatectomy
lymph node dissection
brachytherapy
hormonal therapy
neoadjuvant/adjuvant therapy
quality of life
local invasion
On-line přístup:https://directory.doabooks.org/handle/20.500.12854/112486
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky